John Gaffney, Director at Paradigm Biopharmaceuticals Ltd., holds 587.55K shares in Paradigm Biopharmaceuticals Ltd. (Ticker: PBIGF). Most recently, John Gaffney Sold $115,695 shares of Paradigm Biopharmaceuticals Ltd. on May 12, 2020 for an estimated value of 274.12K.